article thumbnail

UK chip designer Arm valued at $51 a share ahead of Wall Street IPO

The Guardian: Mergers & Acquisitions

British tech firm valued at $52.3bn before highly anticipated flotation on Nasdaq by private owner SoftBank The British chip designer Arm has secured a $52.3bn (£41.9bn) valuation in its initial public offering (IPO), before its highly anticipated return to the stock market in New York on Thursday. Continue reading.

IPO 100
article thumbnail

SoftBank Needs a Hit, and It’s Betting on Arm

The New York Times: Mergers, Acquisitions and Dive

Softbank’s chief executive, Masayoshi Son, believes the chip design company he bought in 2016 is poised to reap the fruits of the A.I. revolution.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Considerations for Dual-Class Companies Contemplating M&A Transactions

The Harvard Law School Forum

The rise of founder-led, venture capital-backed companies in recent years has coincided with a surge of companies implementing dual-class share structures in connection with their initial public offerings. more…).

M&A 103
article thumbnail

Fifteen ways to raise £1 million in business finance

Growth Business

3) Aquis Stock Exchange Aquis Stock Exchange , run by NEX, allows businesses to raise capital through Initial Public Offerings (IPOs). >See You can even raise the whole £1m in one go – Monzo did this in 96 seconds back in 2016 through Crowdcube.

Finance 75
article thumbnail

Transfer Traps: Considerations for Dual-Class Companies Contemplating M&A Transactions

Cooley M&A

The rise of founder-led, venture capital-backed companies in recent years has coincided with a surge of companies implementing dual-class share structures in connection with their initial public offerings. 17] This approach was used by LinkedIn, a dual-class company, in its acquisition by Microsoft (announced on June 13, 2016).

M&A 59
article thumbnail

Cooley’s 2022 Life Sciences M&A Year in Review

Cooley M&A

Although there were 104 initial public offerings of biotechnology companies in 2021 that raised nearly $15 billion in funds, 2022 saw only 22 such IPOs collectively raising less than $2 billion. Let’s dig in.

M&A 40